Hometeam

Hometeam gets $27.5M for its mobile-enabled senior care service

The company provides families expert caregiver matching, iPads preloaded with their own software, and a care team to promote healthy and active days.
Zipnosis

Zipnosis raises $17M Series A for its telehealth solution

The company's solution enables health systems to launch their own branded virtual care service line staffed with their own clinicians.
Picwell

Picwell raises another $3M to help users pick the right health insurance

The company offers its services through partnerships with retail pharmacies, payers, self-insured employers, exchanges and brokers.
HealPros

HealPros raises Series A for its mobile diabetic retinopathy service

The company will use the funds, provided by New York-based Sopris Capital, to expand its program into at least twenty-five states in 2016.
Cue and Cue app

Japan’s Dentsu Ventures invests in laboratory-in-a-box maker Cue

Cue's cube-shaped hardware accepts proprietary diagnostic cartridges to provide easy at-home analysis of healthcare data at the molecular level.
GlucoVista

GlucoVista raises $2.7M for its noninvasive continuous glucose monitoring tech

The company's CGM-305 device captures the natural thermal infrared radiation emitted from the glucose in the blood of a human body in specific wave-lengths.
Cohero Health

Cohero Health gets $2M for its respiratory disease management platform

The company's connected devices and mobile apps engage and empower respiratory patients by measuring lung function and tracking adherence.
StartupHealth 2015 chart

StartUp Health: Digital health companies raised $5.8B this year

In 2015, we saw fewer deals (477) than in 2014 (561), but companies that are raising are able to do so faster than in 2014.
Obino

India’s Obino raises seed round for its weight loss coaching platform

With the help of nutritionists on and using artificial intelligence technology, the service personalizes content for each user.
BlueStar app

WellDoc gets $22M Series B for its diabetes management solution

The company will use the funds to accelerate adoption of BlueStar mobile prescription therapy for adults living with type 2 diabetes.